Search

Your search keyword '"Sordet, C."' showing total 284 results
Start Over Author "Sordet, C."
284 results on '"Sordet, C."'

1. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies

Author

Gocko, X., Lenormand, C., Lemogne, C., Bouiller, K., Gehanno, J.-F., Rabaud, C., Perrot, S., Eldin, C., de Broucker, T., Roblot, F., Toubiana, J., Sellal, F., Vuillemet, F., Sordet, C., Fantin, B., Lina, G., Sobas, C., Jaulhac, B., Figoni, J., Chirouze, C., Hansmann, Y., Hentgen, V., Caumes, E., Dieudonné, M., Picone, O., Bodaghi, B., Gangneux, J.-P., Degeilh, B., Partouche, H., Saunier, A., Sotto, A., Raffetin, A., Monsuez, J.-J., Michel, C., Boulanger, N., Cathebras, P., and Tattevin, P.

Published
2019
Full Text
View/download PDF

2. Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis

Author

Figoni, J., Chirouze, C., Hansmann, Y., Lemogne, C., Hentgen, V., Saunier, A., Bouiller, K., Gehanno, J.F., Rabaud, C., Perrot, S., Caumes, E., Eldin, C., de Broucker, T., Jaulhac, B., Roblot, F., Toubiana, J., Sellal, F., Vuillemet, F., Sordet, C., Fantin, B., Lina, G., Gocko, X., Dieudonné, M., Picone, O., Bodaghi, B., Gangneux, J.P., Degeilh, B., Partouche, H., Lenormand, C., Sotto, A., Raffetin, A., Monsuez, J.J., Michel, C., Boulanger, N., Cathebras, P., and Tattevin, P.

Published
2019
Full Text
View/download PDF

3. Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies (II). Biological diagnosis, treatment, persistent symptoms after documented or suspected Lyme borreliosis

Author

Jaulhac, B., Saunier, A., Caumes, E., Bouiller, K., Gehanno, J.F., Rabaud, C., Perrot, S., Eldin, C., de Broucker, T., Roblot, F., Toubiana, J., Sellal, F., Vuillemet, F., Sordet, C., Fantin, B., Lina, G., Sobas, C., Gocko, X., Figoni, J., Chirouze, C., Hansmann, Y., Hentgen, V., Cathebras, P., Dieudonné, M., Picone, O., Bodaghi, B., Gangneux, J.P., Degeilh, B., Partouche, H., Lenormand, C., Sotto, A., Raffetin, A., Monsuez, J.J., Michel, C., Boulanger, N., Lemogne, C., and Tattevin, P.

Published
2019
Full Text
View/download PDF

4. SNAPSJIA — Enquête sur les besoins des adolescents et l’opinion des parents sur la santé sexuelle dans l’arthrite juvénile idiopathique

Author

Savel, C., primary, Chausset, A., additional, Berland, P., additional, Guiguet-Auclair, C., additional, Cabane, L., additional, Fautrel, B., additional, Gaudin, P., additional, Guillot, P., additional, Hayem, G., additional, Lafarge, D., additional, Merlin, E., additional, Peziere, N., additional, Sordet, C., additional, Tropé, S., additional, Tournadre, A., additional, Malochet-Guinamand, S., additional, and Cohen, J.D., additional

Published
2023
Full Text
View/download PDF

5. Evaluation globale standardisée systématique : quelles pratiques en France ?

Author

Fogel, O., primary, Ruyssen-Witrand, A., additional, Portillo, D. Caillet, additional, Najm, A., additional, Baillet, A., additional, Claudepierre, P., additional, Conort, O., additional, Dernis, E., additional, Fayet, F., additional, Gossec, L., additional, Goupille, P., additional, Hudry, C., additional, Letarouilly, J.G., additional, Lukas, C., additional, Marotte, H., additional, Molto, A., additional, Pouplin, S., additional, Senbel, E., additional, Sordet, C., additional, Tournadre, A., additional, Truchetet, M.E., additional, Wendling, D., additional, Maire, E., additional, and Dougados, M., additional

Published
2023
Full Text
View/download PDF

6. Utilité de l’échographie expliquée aux patients et des outils visuels dans les décisions thérapeutiques des patients atteints de polyarthrite rhumatoïde : étude qualitative ADHER-ECHO

Author

Mangez, M., primary, Louati, K., additional, Montagu, G., additional, Griffoul, I., additional, Desailly-Henry, I., additional, Poivret, D., additional, Deparis, N., additional, Sohby-Danial, J.M., additional, Poilverd, R.M., additional, Tropé, S., additional, Alliot-Launois, F., additional, Berard, L., additional, Rat, A.C., additional, Sordet, C., additional, and Beauvais, C., additional

Published
2023
Full Text
View/download PDF

7. Proposition d’un compte rendu standardisé pour une évaluation globale de la spondyloarthrite axiale par une approche basée sur les preuves et un consensus d’experts en rhumatologie (rencontres d’experts en rhumatologie)

Author

Ruyssen-Witrand, A., primary, Portillo, D. Caillet, additional, Najm, A., additional, Fogel, O., additional, Baillet, A., additional, Claudepierre, P., additional, Conort, O., additional, Dernis, E., additional, Fayet, F., additional, Gossec, L., additional, Goupille, P., additional, Hudry, C., additional, Letarouilly, J.G., additional, Lukas, C., additional, Marotte, H., additional, Molto, A., additional, Pouplin, S., additional, Senbel, E., additional, Sordet, C., additional, Tournadre, A., additional, Truchetet, M.E., additional, Wendling, D., additional, and Dougados, M., additional

Published
2023
Full Text
View/download PDF

8. POS0794-HPR SNAPS JIA - SURVEY OF ADOLESCENTS’ NEEDS AND PARENTS’ VIEWS ON SEXUAL HEALTH IN JUVENILE IDIOPATHIC ARTHRITIS

Author

Savel, C., primary, Chausset, A., additional, Berland, P., additional, Guiguet-Auclair, C., additional, Cabane, L., additional, Fautrel, B., additional, Gaudin, P., additional, Guillot, P., additional, Hayem, G., additional, Lafarge, D., additional, Malochet, S., additional, Merlin, E., additional, Peziere, N., additional, Sordet, C., additional, Tropé, S., additional, Tournadre, A., additional, and Cohen, J. D., additional

Published
2023
Full Text
View/download PDF

11. Coordination régionale et suivi prospectif du traitement prophylactique et curatif de 301 patients traités par anticorps monoclonaux anti-SARS-CoV-2

Author

Licinio, P., primary, Weil, M., additional, Morel, M.H., additional, Braun, D. Marin, additional, Gourieux, B., additional, Klein, C., additional, Sordet, C., additional, Chatelus, E., additional, Felten, R., additional, Meyer, A., additional, Sibilia, J., additional, Hirschi, S., additional, Degot, T., additional, Picard, B. Renaud, additional, Virot, E., additional, Michard, B., additional, Kremer, L.D., additional, Bigault, K., additional, Cevallos, R., additional, Lefebvre, N., additional, Hansmann, Y., additional, Bronner, C., additional, Rybarczyk-Vigouret, M.C., additional, Pain, L., additional, and Gottenberg, J.E., additional

Published
2022
Full Text
View/download PDF

14. POS1223 DIFFERENT ANTI-SARS-CoV-2 VACCINE RESPONSE UNDER B- AND T-CELL TARGETED THERAPIES VERSUS ANTI-CYTOKINE THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES

Author

Felten, R., primary, Geoffroy, M., additional, Loïs, B., additional, Duret, P. M., additional, Desmurs, M., additional, Fan, A., additional, Couderc, M., additional, Messer, L., additional, Ardizzone, M., additional, Ahmed-Yahia, S., additional, Javier, R. M., additional, Meyer, A., additional, Chatelus, E., additional, Sordet, C., additional, Pijnenburg, L., additional, Sibilia, J., additional, Soubrier, M., additional, Gottenberg, J. E., additional, and Salmon, J. H., additional

Published
2022
Full Text
View/download PDF

15. POS0711 TOLERANCE AND EFFICACY OF TARGETED THERAPIES PRESCRIBED FOR OFF-LABEL INDICATIONS IN REFRACTORY SYSTEMIC AUTOIMMUNE DISEASES: DATA OF THE FIRST 100 PATIENTS ENROLLED IN THE TATA REGISTRY (TARGETED THERAPY IN AUTOIMMUNE DISEASES)

Author

Gottenberg, J. E., primary, Chaudier, A., additional, Allenbach, Y., additional, Mekinian, A., additional, Amoura, Z., additional, Cacoub, P., additional, Cornec, D., additional, Hachulla, E., additional, Quartier, P., additional, Melki, I., additional, Richez, C., additional, Seror, R., additional, Terrier, B., additional, Devauchelle-Pensec, V., additional, Henry, J., additional, Gatfosse, M., additional, Bouillet, L., additional, Gaigneux, E., additional, Andre, V., additional, Baulier, G., additional, Saunier, A., additional, Desmurs, M., additional, Poulet, A., additional, Ete, M., additional, Truchetet, M. E., additional, Michaud, M., additional, Larroche, C., additional, Dellal, A., additional, Leurs, A., additional, Ottaviani, S., additional, Nielly, H., additional, Vial, G., additional, Jaussaud, R., additional, Rouviere, B., additional, Jeandel, P. Y., additional, Guffroy, A., additional, Korganow, A. S., additional, Jouvray, M., additional, Meyer, A., additional, Chatelus, E., additional, Sordet, C., additional, Felten, R., additional, Sibilia, J., additional, Ahmed Yahia, S., additional, Kleinmann, J. F., additional, and Mariette, X., additional

Published
2022
Full Text
View/download PDF

18. Tolérance et efficacité des thérapies ciblées prescrites dans des indications hors AMM au cours des maladies auto-immunes systémiques réfractaires : données des 100 premiers patients inclus dans le registre TATA (TArgeted Therapy in Auto-immune Diseases)

Author

Chaudier, A., primary, Allenbach, Y., additional, Mekinian, A., additional, Richez, C., additional, Truchetet, M.E., additional, Hachulla, E., additional, Amoura, Z., additional, Devauchelle-Pensec, V., additional, Terrier, B., additional, Meyer, A., additional, Chatelus, E., additional, Sordet, C., additional, Arnaud, L., additional, Sibilia, J., additional, Samira, A.Y., additional, Kleinmann, J.F., additional, Cacoub, P., additional, Seror, R., additional, Mariette, X., additional, and Gottenberg, J., additional

Published
2021
Full Text
View/download PDF

19. Arthrite juvénile idiopathique et Covid-19 : impact de la pandémie sur le traitement et le retour à l’école

Author

Quéré, B., primary, Lemelle, I., additional, Lohse, A., additional, Pillet, P., additional, Molimard, J., additional, Richer, O., additional, Sordet, C., additional, Despert, V., additional, Rossi-Semerano, L., additional, Borocco, C., additional, Koné-Paut, I., additional, Gervais, E., additional, Guellec, D., additional, and Devauchelle Pensec, V., additional

Published
2021
Full Text
View/download PDF

21. Tolérance et efficacité des thérapies ciblées prescrites hors AMM au cours des maladies auto-immunes systémiques réfractaires : données des 100 premiers patients inclus dans le registre TATA (TArgeted Therapy in Autoimmune Diseases)

Author

Gottenberg, J.E., primary, Chaudier, A., additional, Allenbach, Y., additional, Mékinian, A., additional, Richez, C., additional, Truchetet, M.E., additional, Hachulla, E., additional, Amoura, Z., additional, Devauchelle Pensec, V., additional, Cornec, D., additional, Quartier, P., additional, Terrier, B., additional, Henry, J., additional, Gatfosse, M., additional, Jouvray, M., additional, Bouillet, L., additional, Gaigneux, E., additional, André, V., additional, Baulier, G., additional, Saunier, A., additional, Desmurs, M., additional, Poulet, A., additional, Ete, M., additional, Bienvenu, B., additional, Michaud, M., additional, Larroche, C., additional, Dellal, A., additional, Leurs, A., additional, Ottaviani, S., additional, Nielly, H., additional, Vial, G., additional, Jaussaud, R., additional, Moulinet, T., additional, Guffroy, A., additional, Meyer, A., additional, Chatelus, E., additional, Sordet, C., additional, Felten, R., additional, Ahmed Yahia, S., additional, Kleinmann, J.F., additional, Cacoub, P., additional, Seror, R., additional, and Mariette, X., additional

Published
2021
Full Text
View/download PDF

27. POS1190 EXPECTATIONS AND POTENTIAL CONCERNS OF PATIENTS WITH AUTOIMMUNE AND RHEUMATIC DISEASES REGARDING VACCINATION AGAINST SARS-CoV-2 (COVID-19): THE WORLDWIDE ONLINE VAXICOV STUDY

Author

Felten, R., primary, Dubois, M., additional, Ugarte-Gil, M. F., additional, Fort, J., additional, Pijnenburg, L., additional, Chaudier, A., additional, Kawka, L., additional, Costecalde, C., additional, Bergier, H., additional, Chatelus, E., additional, Javier, R. M., additional, Sordet, C., additional, Gottenberg, J. E., additional, Sibilia, J., additional, Fuentes-Silva, Y., additional, and Arnaud, L., additional

Published
2021
Full Text
View/download PDF

28. POS1314 JUVENILE IDIOPATHIC ARTHRITIS IN THE CONTEXT OF THE CORONAVIRUS DISEASE 19 PANDEMIC: IMPACT ON THE DECREASE IN TREATMENT AND THE RETURN TO SCHOOL

Author

Quéré, B., primary, Lemelle, I., additional, Lohse, A., additional, Pillet, P., additional, Molimard, J., additional, Richer, O., additional, Sordet, C., additional, Despert, V., additional, Rossi-Semerano, L., additional, Borocco, C., additional, Koné-Paut, I., additional, Gervais, E., additional, Guellec, D., additional, and Devauchelle-Pensec, V., additional

Published
2021
Full Text
View/download PDF

31. Prévalence du COVID-19 et des poussées inflammatoires chez les patients atteints de maladie auto-immunes systémiques rares : enquête systématique téléphonique et sérologique dans un centre national de référence

Author

Felten, R., primary, Scherlinger, M., additional, Kleinmann, J.F., additional, Sordet, C., additional, Meyer, A., additional, Chatelus, E., additional, Pijnenburg, L., additional, Poindron, V., additional, Guffroy, A., additional, Javier, R.M., additional, Korganow, A.S., additional, Martin, T., additional, Gottenberg, J.E., additional, Sibilia, J., additional, and Arnaud, L., additional

Published
2020
Full Text
View/download PDF

32. OP0125 LYMPHOMAS COMPLICATING RHEUMATOID ARTHRITIS: RESULTS OF A FRENCH MULTI-CENTRE CASE-CONTROL STUDY

Author

Kedra, J., primary, Seror, R., additional, Dieudé, P., additional, Constantin, A., additional, Toussirot, E., additional, Kfoury, E., additional, Masson, C., additional, Cornec, D., additional, Dubost, J. J., additional, Marguerie, L., additional, Ottaviani, S., additional, Grados, F., additional, Belkhir, R., additional, Fain, O., additional, Goupille, P., additional, Sordet, C., additional, Fautrel, B., additional, Philippe, P., additional, Piperno, M., additional, Combe, B., additional, Lambotte, O., additional, Richez, C., additional, Sellam, J., additional, Sene, T., additional, Denis, G., additional, Lequerre, T., additional, Mariette, X., additional, and Nocturne, G., additional

Published
2020
Full Text
View/download PDF

37. Borréliose de Lyme et autres maladies vectorielles à tiques. Recommandations des sociétés savantes françaises

Author

Gocko, X., Lenormand, C., Lemogne, C., Bouiller, K., Gehanno, J.-F., Rabaud, C., Perrot, S., Eldin, C., De Broucker, T., Roblot, F., Toubiana, J., Sellal, F., Vuillemet, F., Sordet, C., Fantin, B., Lina, G., Sobas, C., JAULHAC, B., Figoni, J., Chirouze, C., Hansmann, Y., Hentgen, V., Caumes, E., Dieudonné, M., Picone, O., Bodaghi, B., Gangneux, J.-P., Degeilh, B., Partouche, H., Saunier, A., Sotto, A., Raffetin, A., Monsuez, J.-J., Michel, C., Boulanger, N., Cathébras, P., Tattevin, P., CHU Rouen, Normandie Université (NU), Université Paris Descartes - Paris 5 (UPD5), Laboratoire Chrono-environnement - UFC (UMR 6249) (LCE), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), service de maladies infectieuses CHU J Minjoz Besancon, Hôpital Jean Minjoz, Haut Conseil de la Santé Publique, Vecteurs - Infections tropicales et méditerranéennes (VITROME), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut de Recherche Biomédicale des Armées (IRBA), Service de neurologie [CH Saint Denis], Centre Hospitalier de Saint-Denis [Ile-de-France], Médecine interne [ Poitiers], Centre hospitalier universitaire de Poitiers (CHU Poitiers), Hôpital de Hautepierre [Strasbourg], Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Centre National de référence des Staphylocoques, Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL), CHU Strasbourg, Service de maladies infectieuses et tropicales, Service de Pédiatrie, Centre Hospitalier de Versailles André Mignot (CHV), Centre Max Weber (CMW), Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet [Saint-Étienne] (UJM), Service de Parasitologie-Mycologie [Rennes], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Estación Biológica de Doñana CSIC (SPAIN), Centre Hospitalier Régional Universitaire de Nîmes (CHRU Nîmes), Centre Hospitalier Intercommunal Villeneuve-Saint-Georges (CHIV), Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Service des maladies infectieuses et réanimation médicale, and Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou

Subjects
Borréliose de Lyme, Recommandations, Maladies à tiques, ComputingMilieux_MISCELLANEOUS, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Abstract

International audience

Published
2019
Full Text
View/download PDF

38. Borréliose de Lyme et autres maladies vectorielles à tiques. Recommandations des sociétés savantes françaises (Argumentaire I) : prévention, épidémiologie, circonstances du diagnostic

Author

Figoni, J, Chirouze, C, Hansmann, Y, Lemogne, C, Hentgen, V, Saunier, A, Bouiller, K, Gehanno, J F, Rabaud, C, Perrot, S, Caumes, E, Eldin, C, de Broucker, T, Jaulhac, B, Roblot, F, Toubiana, J, Sellal, F, Vuillemet, F, Sordet, C, Fantin, B, Lina, G, Gocko, X, Dieudonné, M, Picone, O., Bodaghi, B, Gangneux, Jean-Pierre, Degeilh, B, Partouche, H, Lenormand, C, Sotto, A, Raffetin, A, Monsuez, J J, Michel, C, Boulanger, N, Cathebras, P, Tattevin, P, Santé publique France - French National Public Health Agency [Saint-Maurice, France], Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Université Paris-Est Marne-la-Vallée (UPEM), Institut de psychiatrie et neurosciences de Paris (IPNP - U1266 Inserm - Paris Descartes), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de santé au travail et pathologie professionnelle [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Laboratoire d'Informatique Médicale et Ingénierie des Connaissances en e-Santé (LIMICS), Université Paris 13 (UP13)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Service des maladies infectieuses et tropicales [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Pharmacologie des anti-infectieux (PHAR), Université de Poitiers-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospices Civils de Lyon, Departement de Neurologie (HCL), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Max Weber (CMW), Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet [Saint-Étienne] (UJM), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), École des Hautes Études en Santé Publique [EHESP] (EHESP), Université de Strasbourg (UNISTRA), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), CHU Pontchaillou [Rennes], Service de Maladies Infectieuses et Tropicales [CHU Pitié-Salpêtrière], École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet [Saint-Étienne] (UJM)-Centre National de la Recherche Scientifique (CNRS), Santé publique France, Laboratoire Chrono-environnement - UFC (UMR 6249) (LCE), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Centre National de la Recherche Scientifique (CNRS)-Université Jean Monnet [Saint-Étienne] (UJM)-Université Lumière - Lyon 2 (UL2)-École normale supérieure - Lyon (ENS Lyon), Laboratoire Chrono-environnement (UMR 6249) (LCE), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), École normale supérieure de Lyon (ENS de Lyon)-Université Lumière - Lyon 2 (UL2)-Université Jean Monnet - Saint-Étienne (UJM)-Centre National de la Recherche Scientifique (CNRS), and Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )

Subjects
Prévention, Erythema migrans, Neuroborreliosis, Arthritis, [SDV]Life Sciences [q-bio], Borréliose de Lyme, Ticks, Arthrite, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Érythème migrant, France, Tiques, ComputingMilieux_MISCELLANEOUS, Neuroborréliose, Lyme borreliosis
Abstract

International audience

Published
2019
Full Text
View/download PDF

39. Lyme borreliosis and other tick-borne diseases. Guidelines from the French Scientific Societies (I): prevention, epidemiology, diagnosis: prevention, epidemiology, diagnosis

Author

Figoni, J. (J), Chirouze, C. (C), Hansmann, Y. (Yves), Lemogne, C. (C), Hentgen, V. (V), Saunier, A. (A), Bouiller, K. (K), Gehanno, J. (J) F. (F), Rabaud, C. (C), Perrot, S. (S), Caumes, E. (E), Eldin, C. (C), de Broucker, T. (T), Jaulhac, B. (Benoit), Roblot, F. (F), Toubiana, J. (J), Sellal, F. (Francois), Vuillemet, F. (F), Sordet, C. (Christelle), Fantin, B. (B), Lina, G. (G), Gocko, X. (X), Dieudonné, M. (M), Picone, O. (O), Bodaghi, B. (B), Gangneux, J. (J) P. (P), Degeilh, B. (B), Partouche, H. (H), Lenormand, C. (Cedric), Sotto, A. (A), Raffetin, A. (A), Monsuez, J. (J) J. (J), Michel, C. (C), Boulanger, N. (Nathalie), Cathebras, P. (P), and Tattevin, P. (P)

Subjects
Aucun, Sciences du Vivant [q-bio]/Microbiologie et Parasitologie
Abstract

Lyme borreliosis is transmitted en France by the tick Ixodes ricinus, endemic in metropolitan France. In the absence of vaccine licensed for use in humans, primary prevention mostly relies on mechanical protection (clothes covering most parts of the body) that may be completed by chemical protection (repulsives). Secondary prevention relies on early detection of ticks after exposure, and mechanical extraction. There is currently no situation in France when prophylactic antibiotics would be recommended. The incidence of Lyme borreliosis in France, estimated through a network of general practitioners (réseau Sentinelles), and nationwide coding system for hospital stays, has not significantly changed between 2009 and 2017, with a mean incidence estimated at 53 cases/100,000 inhabitants/year, leading to 1.3 hospital admission/100,000 inhabitants/year. Other tick-borne diseases are much more seldom in France: tick-borne encephalitis (around 20 cases/year), spotted-fever rickettsiosis (primarily mediterranean spotted fever, around 10 cases/year), tularemia (50–100 cases/year, of which 20% are transmitted by ticks), human granulocytic anaplasmosis (< 10 cases/year), and babesiosis (< 5 cases/year). The main circumstances of diagnosis for Lyme borreliosis are cutaneous manifestations (primarily erythema migrans, much more rarely borrelial lymphocytoma and atrophic chronic acrodermatitis), neurological (< 15% of cases, mostly meningoradiculitis and cranial nerve palsy, especially facial nerve) and rheumatologic (mostly knee monoarthritis, with recurrences). Cardiac and ophtalmologic manifestations are very rarely encountered.

Published
2019

45. Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?

Author

Michel Velten, Sordet C, Bruno Michel, Sibilia J, M.C. Rybarczyk-Vigouret, and Morgane Beck

Subjects
musculoskeletal diseases, 030203 arthritis & rheumatology, medicine.medical_specialty, Health economics, business.industry, Biosimilar, medicine.disease, Infliximab, Etanercept, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Rheumatoid arthritis, Physical therapy, Adalimumab, Medicine, Original Article, Observational study, General Pharmacology, Toxicology and Pharmaceutics, Medical prescription, business, Intensive care medicine, health care economics and organizations, medicine.drug
Abstract

Objectives Biosimilar infliximab, the first similar biological medicinal product containing monoclonal antibodies to be commercialised, is likely to contribute to a significant reduction in healthcare costs. We aimed to assess the cost savings potential over 1 year of the use of biosimilar infliximab for the treatment of rheumatoid arthritis (RA) patients in Alsace and in France, in a real-life setting. Methods The analysis was based on a previously conducted observational study which evaluated the annual cost of the care of patients with RA treated with biological therapies in 2012 in Alsace. Average annual costs to manage RA patients were calculated, taking into account the decrease in the retail price between 2012 and 2015 (as given in the official national price list) and the local negotiated price for biosimilar infliximab. Annual cost savings for different biosimilar prescription scenarios were calculated using 2015 prices. Results Management of RA patients with biosimilar infliximab was significantly cheaper than with adalimumab or etanercept (€11 907 vs €12 981 and €13 551, respectively). The projected annual cost savings reached €13.6 million nationally, if all adult RA patients treated with the originator infliximab switched to the biosimilar drug. These savings, if fully reallocated for the treatment of RA, would enable the treatment of 1141 additional patients. Conclusions The study showed a positive financial impact of introducing biosimilar infliximab for the treatment of RA patients in France. Such savings could contribute to improved patient care by allowing more patients to be treated without more money being spent.

Published
2016
Full Text
View/download PDF

46. Erratum à « Borréliose de Lyme et autres maladies vectorielles à tiques. Recommandations des sociétés savantes françaises » [Med. Mal. Infect. 49 (2019) 296–317]

Author

Gocko, X., primary, Lenormand, C., additional, Lemogne, C., additional, Bouiller, K., additional, Gehanno, J.-F., additional, Rabaud, C., additional, Perrot, S., additional, Eldin, C., additional, de Broucker, T., additional, Roblot, F., additional, Toubiana, J., additional, Sellal, F., additional, Vuillemet, F., additional, Sordet, C., additional, Fantin, B., additional, Lina, G., additional, Sobas, C., additional, Jaulhac, B., additional, Figoni, J., additional, Chirouze, C., additional, Hansmann, Y., additional, Hentgen, V., additional, Caumes, E., additional, Dieudonné, M., additional, Picone, O., additional, Bodaghi, B., additional, Gangneux, J.-P., additional, Degeilh, B., additional, Partouche, H., additional, Saunier, A., additional, Sotto, A., additional, Raffetin, A., additional, Monsuez, J.-J., additional, Michel, C., additional, Boulanger, N., additional, Cathebras, P., additional, and Tattevin, P., additional

Published
2019
Full Text
View/download PDF

50. SAT0112 Prevalence and incidence over 3 years of different comorbidities in rheumatoid arthritis (RA): a 3 year longitudinal study in 769 established ra patients

Author

Gossec, L, primary, Soubrier, M, additional, Foissac, F, additional, Fayet, F, additional, Balandraud, N, additional, Bardin, T, additional, Beauvais, C, additional, Chales, G, additional, Chary-Valckenaere, I, additional, Dernis, E, additional, Euller-Ziegler, L, additional, Flipo, R-M, additional, Gilson, M, additional, Marhadour, T, additional, Mariette, X, additional, Mouterde, G, additional, Pouplin, S, additional, Richette, P, additional, Ruyssen-Witrand, A, additional, Schaeverbeke, T, additional, Sordet, C, additional, and Dougados, M, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results